发明授权
- 专利标题： Composition for inhibition of cathepsin K
- 专利标题（中）： 用于抑制组织蛋白酶K的组合物
-
申请号： US11885421申请日： 2006-02-24
-
公开(公告)号： US08722734B2公开(公告)日： 2014-05-13
- 发明人: Anastasia Daifotis , Selwyn Aubrey Stoch , Basil Avery Ince , Cameron Black
- 申请人： Anastasia Daifotis , Selwyn Aubrey Stoch , Basil Avery Ince , Cameron Black
- 申请人地址： US NJ Rahway CA Quebec
- 专利权人： Merck Sharp & Dohme Corp.,Merck Canada Inc.
- 当前专利权人： Merck Sharp & Dohme Corp.,Merck Canada Inc.
- 当前专利权人地址： US NJ Rahway CA Quebec
- 代理商 Nicole M. Beeler; Catherine D. Fitch
- 国际申请： PCT/US2006/006622 WO 20060224
- 国际公布： WO2007/046842 WO 20070426
- 主分类号： A01N37/34
- IPC分类号： A01N37/34
摘要：
The present invention relates to the a method of inhibiting bone resorption in a mammal in need thereof with an oral pharmaceutical composition comprising a cathepsin K inhibitor, or a pharmaceutically acceptable salt thereof, or a mixture thereof, according to a continuous schedule having a dosage interval of once weekly, biweekly, twice monthly or once monthly.
公开/授权文献
- US20080255072A1 Composition for Inhibition of Cathepsin K 公开/授权日：2008-10-16
信息查询
